BlackRock Fund Advisors’s Arcadia Biosciences RKDA Stock Holding History

BlackRock Fund Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33K	Buy	45 +1	+2%	+$1.14K	﹤0.01%	3831
2016 Q3	$68K	Hold	44	–	–	﹤0.01%	3703
2016 Q2	$90K	Sell	44 -217	-83%	-$363K	﹤0.01%	3698
2016 Q1	$581K	Sell	261 -13	-5%	-$27.6K	﹤0.01%	3221
2015 Q4	$665K	Buy	274 +9	+3%	+$23.4K	﹤0.01%	3257
2015 Q3	$646K	Sell	265 -2	-0.7%	-$8.32K	﹤0.01%	3221
2015 Q2	$1.36M	Buy	+267	New	+$1.66M	﹤0.01%	3197

Other funds holding RKDA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

BlackRock Fund Advisors's RKDA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Arcadia Biosciences (RKDA) stake by 2.3% in Q4 2016, buying an estimated $1.14K and bringing the position to 45 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3831.

BlackRock Fund Advisors first reported a position in RKDA in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.36M in Q2 2015. 12 funds tracked by Wall St. Rank hold RKDA as of Q4 2016.

BlackRock Fund Advisors held 45 shares of Arcadia Biosciences worth $33K as of Q4 2016.
BlackRock Fund Advisors bought 1 Arcadia Biosciences share in Q4 2016, an estimated $1.14K.
Arcadia Biosciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3831 holding.
BlackRock Fund Advisors first reported a position in Arcadia Biosciences in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Arcadia Biosciences position peaked at $1.36M in Q2 2015.
12 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.